On The Fly: After Hours Movers
UP AFTER EARNINGS: Buffalo Wild Wings (BWLD), up 20.1%... Echo Global (ECHO), up 7.1%... Agnico Eagle (AEM), up 5.2%... Whiting Petroleum (WLL), up 4.3%... Biggs...
Author : The Fly
On The Fly: Top stock stories for Wednesday
Stocks opened in negative territory and from there the sellers took control and pushed the Nasdaq to losses of about 1%. The averages were able...
Foot Locker jumps 2% as Nike discusses partnerships at investor event
The move higher in Foot Locker (FL) is being attributed to comments made by Nike (NKE), which is currently hosting its investor day meeting. During...
Battleground: Analysts diverge on AMD amid cryptocurrency, margin concerns
While AMD (AMD) reported better than expected third quarter earnings and revenue yesterday, the chipmaker's shares are sliding amid rising concerns over profits and cryptocurrency...
Northrop Grumman says won’t submit bid on Navy’s MQ-25 program
On its Q3 earnings conference call, Northrop Grumman confirmed that notified the Navy that it will not be submitting a bid on the MQ-25 program....
On The Fly: Top stock stories at midday
Stocks opened little changed but have seen some profit taking in the early hours of trading. The Nasdaq is leading the market lower with losses...
On The Fly: What to watch in media networks earnings reports
The owners of several of the country's biggest media networks are scheduled to report quarterly results over the next two weeks, with CBS and Showtime...
On The Fly: What to watch in Twitter earnings report
Twitter (TWTR) is scheduled to report results of its third fiscal quarter before the market open on October 26, with a conference call scheduled for...
General Motors downgraded to Equal Weight at Morgan Stanley
As previously reported, Morgan Stanley analyst Adam Jonas downgraded General Motors to Equal Weight from Overweight following the stock's 40% rise over the past year,...
Biogen upgraded to Outperform from Market Perform at BMO Capital
BMO Capital analyst M. Ian Somaiya upgraded Biogen to Outperform saying risks to the multiple sclerosis franchise and Spinraza are getting "quickly priced in" following...